openPR Logo
Press release

Renal Biomarker Market Globally Expected to Drive Growth through 2026

09-27-2016 09:08 AM CET | Health & Medicine

Press release from: Future Market Insights

Renal Biomarker Market Globally Expected to Drive Growth

Currently diagnosis of many diseases is obligated to detection of several disease specific markers referred to as biomarker. European Medical Agency defines biomarkers as measurable characteristics that reflect physiological, pharmacological progression of a disease. Renal diseases including acute kidney injury, chronic kidney disease, glomerular disease, preeclampsia etc., have a high mortality and morbidity rate and are characterized by the rapid or gradual loss of kidney function resulting into serous clinical implications. The gold standard for diagnosis of renal injury i.e. routine estimation of serum creatinine lack sufficient sensitivity for early detection of injury and are not specific for the site of injury having limited clinical utility. In case of diseases such as acute kidney disease and chronic kidney disease creatinine takes several days to reach the steady state and up to 50 % of the kidney function may be lost before the serum creatinine begins to rise during the kidney injury. Hence, there is an impending need of development of specific biomarker that can detect the renal disorders at the earliest which helps in timely preventive or more effective treatments for management of renal disorders. A number of emerging biomarkers are currently being developed in order to help early diagnose and prevent catastrophic outcomes of various renal disorders in clinical practice. The most promising biomarkers of acute kidney injury (AKI) for clinical use include a plasma panel (NGAL and cystatin C) and a urine panel (NGAL, Il-18 and KIM-1).

The major factors fuelling the need for development of novel renal biomarkers includes increasing prevalence of various kidney disorders, along with growing incidence of other chronic disorders such as diabetes, obesity and hypertension, as these diseases are often associated with the gradual loss of kidney function.

Renal Biomarker Market: Drivers and Restraints

The incidence of chronic kidney diseases (CKD) is increasing rapidly in aging population. The National Institute of Diabetes and Digestive and Kidney Disease estimates that the prevalence of CKD in people aged 65 and older doubled between 2000 and 2008. CKD continues to be a major cause of lost productivity, physician visits and hospitalizations globally. In addition, factors such as increasing prevalence of diabetes and high blood pressure and cardiovascular disorders also contributes towards the exponential market growth of renal biomarkers in the near future. American kidney Fund, 2012 estimated diabetes as one of the leading cause of kidney failure accounting for 44% of the new cases. Furthermore, increasing investments in research and development will further boost the renal biomarker market growth globally as a large number of renal biomarkers are currently being to assess the safety of new drugs.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1731

However lack of awareness and tight regulations scenario in developing countries is expected to restrain the renal biomarker market growth in the near future.

Renal Biomarker Market: Segmentation

The global renal biomarker market has been classified on the basis of marker type, application, end user and geography.

Based on marker type, the global renal biomarker market is divided into following:

Creatinine

Blood Urea Nitrogen

Cystatin C

Neutrophil Gelatinase-Associated Lipocalin (NGAL)

Kidney Injury Molecule-1 (KIM-1)

Retinol Binding Protein (RBP) Alanine-aminopeptidase (Ala-AP)

Others

Based on the diagnostic tests, the global renal biomarker is divided into following:

Radioimmunoassay (RIA)

Enzyme Linked Immunosorbent Assay (ELISA)

Chemiluminescent Enzyme Immunoassay (CLIA)

Particle-Enhanced Turbidimetric Immunoassay (PETIA)

Liquid Chromatography-Mass Spectrometry

Based on the end user type, the global renal biomarker is divided into following:

Hospitals

Research Centers

Specialty Diagnostic Clinics

Renal Biomarker Market: Overview

Biomarkers are defined to be valuable tools in clinical diagnostics as well as in therapeutic drug discovery and development. In order to improve the care of patients with renal disorders there is a need to develop novel renal biomarkers. However, widespread availability of enabling technologies such as functional genomics and proteomics has also accelerated the rate of novel biomarker discovery for renal diseases globally. Additionally FDA clearance and regulatory approval of revolutionary diagnostic assays are also expected to create the revenue traction in global renal biomarker market in the near future.

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1731

Renal Biomarker Market: Regional Overview

Region wise, the global wide filed imaging systems market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa.North America leads the global renal biomarker market followed by Europe. Growing prevalence of various renal disorders, growing investment in R & D and increased FDA approvals are expected towards the revenue traction in North America. Worldwide market for renal biomarkers is still evolving and major drug development firms and various companies need to work in close coordination with each other in order to develop unique biomarkers for the management of various renal disorders.

Smart Contact Lens: Key Players

Some of the key players in global wide filed imaging systems market are Abbott Diagnostics, F. Hoffmann-La Roche AG, Beckman Coulter Inc., Siemens Healthcare Diagnostics Inc., Thermo Fisher Scientific Inc., Astute Medical Inc., Alere Inc., bioMérieux SA and Randox Laboratories Ltd.

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Renal Biomarker Market Globally Expected to Drive Growth through 2026 here

News-ID: 367246 • Views: 319

More Releases from Future Market Insights

How Changing Dynamics of Cable Testing Market are Reflecting on Growth Strategie …
Global Cable Testing Market: Introduction The cost of the substitution of cables that are concealed is very high. Faults in the cable, bending, kinking, and crushing, are not always visible, which has created the requirement for cable testing. Thus, cable testing helps check the cable functionality, cable quality, and cable conformity. Several times, cable testing by visual inspection is an effective way of identifying the actual problem before it causes any
How Transformative Trends in Self-Organising Network Market are Molding Strategi …
Self-Organising Network: Introduction With accelerated advancements and increasing complexities in the radio network technologies, such as those utilised for the development of LTE and 5G networks, which are used for planning, management, configuration, healing and optimisation, are required to be automated to facilitate efficiency. At present, suppliers are offering self-organising networks that possess the ability to offer optimum performance. Self-organising networks are use cases that perform network governance, including network planning,
Mining Vehicle AC Kits Market: Exploring the Impact of Trends on Strategies of K …
Mining Vehicle AC Kits Market: Introduction Cabin space in mining equipment has become more sophisticated in the recent past. The installation of mining vehicle AC kits has evolved from an optional feature to a necessary feature. Mining equipment manufacturers have made advancements in technology related to efficiency, performance and cost of air conditioning systems in order to make them affordable and economical to enable low-budget and compact installations without compromising on
Key Factors to Fuel Growth of the Talent Acquisition & Staffing Technology and S …
With the growing importance of recruiting and retaining top talent effectively and efficiently, smart hiring processes are the need of the hour. It is about time organisations move beyond merely scrutinising resumes. Salaries and benefits are important factors, but adopting ways that would make candidates an important part of the hiring process will attract the best talent. Studies reveal that due to discrepancies in existing Applicant Tracking Systems (ATS), hiring

All 5 Releases


More Releases for Renal

Acute Renal Failure Epidemiology Insights to 2025
Publisher " Acute Renal Failure ARF Acute Kidney Injury - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Acute Renal Failure ARF Acute Kidney Injury in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Acute Renal Failure ARF Acute Kidney Injury prevalent or incident cases segmented by age, sex and subpopulations. The Report
Renal Insufficiency Market Vendor Growth Landscape 2025
Global Renal Insufficiency Market: Snapshot The demand for renal disease treatment products and therapies has been incrementing steadily in the past few years, owing to the prevalence of poor kidney functions among a vast population base across the world, especially in the Asia Pacific region, and increased government support. However, the participants of the global renal insufficiency market must take a note of weak competition among the marketed products for the
Acute Renal Failure - Pipeline Review, H1 2018
"The Report Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Acute Renal Failure Market Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2018, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury)
Renal Diseases Pharmaceutical and Healthcare Analysis Information
Pune, India, 9th November 2017: WiseGuyReports announced addition of new report, titled “Frontier Pharma: Renal Diseases - High Degree of Innovation and Diversity with Products Targeting Immune and Hormone Signaling Dominating the Pipeline for”. Summary The renal diseases therapy area encompasses a range of diseases of the kidney, such as chronic kidney disease (CKD), acute kidney injury, diabetic nephropathy and focal segmental glomerulosclerosis. Renal diseases are becoming increasingly common due to the
Acute Renal Failure Epidemiology Insights to 2025
Publisher " Acute Renal Failure ARF Acute Kidney Injury - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Acute Renal Failure ARF Acute Kidney Injury in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Acute Renal Failure ARF Acute Kidney Injury prevalent or incident cases segmented by age, sex and subpopulations. The Report
Renal Cluster Drug Development Pipeline Review, 2017
ReportsWorldwide has announced the addition of a new report title Renal Cluster Drug Development Pipeline Review, 2017 to its growing collection of premium market research reports. This report provides an overview of the renal cluster pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Kidney Fibrosis, Chronic Kidney Disease (Chronic Renal Failure), Acute Renal Failure (ARF), Kidney Transplant Rejection, and